Aether Industries Limited (NSEI: AETHER)
Health Care · Pharmaceuticals · IN
Rs1,626.60
+0.09% today · +114.6% 1Y
Aether Industries Limited (NSEI: AETHER) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.26B and employs 970 people.
Over the last twelve months the share price has gained 114.6%, trading between 726.45 and 1.69K.
Tweenvest scores Aether Industries Limited across four factors: quality 63/100, value 34/100, growth 100/100. Its strongest factor is growth.
AETHER price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.26B
- Revenue (TTM)
- $130.09M
- P/E
- 91.66
- EPS
- 17.75
- Dividend yield
- —
- Beta (5Y)
- -0.13
- 52-week high
- Rs1,692.00
- 52-week low
- Rs726.45
- Avg volume (3M)
- —
- Shares outstanding
- 132.71M
- Employees
- 970
- Next earnings
- —
About Aether Industries Limited
Aether Industries Limited operates internationally and within India, specializing in the production and distribution of sophisticated chemical intermediates and specialized chemical compounds. The company's comprehensive product lineup features items such as 4-(2-Methoxyethyl) phenol (4MEP), N-Octyl-D-glucamine (NODG), ortho tolyl benzo nitrile (OTBN), thiophene-2-ethanol (T2E), 1-2-(2Hydroxyethoxy) ethyl piperazine (HEEP), delta-valerolactone (DVL), and bifenthrin alcohol. These chemicals are supplied to a broad array of sectors, including pharmaceuticals, agrochemicals, material science, protective coatings, advanced photography, various additive applications, and the oil and gas industry. Furthermore, Aether Industries extends its expertise through contract research and manufacturing services. Established in 2013, the company's primary operations are situated in Surat, India.
- Founded
- 2013
- Listed since
- Jun 3, 2022
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.22 | -0.96% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.15 | +0.29% |
Figures last refreshed Aug 18, 2026.